Multidrug-Resistant Tuberculosis in Central Asia and Predominant Beijing Lineage, Challenges in Diagnosis, Treatment Barriers, and Infection Control Strategies: An Integrative Review.

Ulan Kozhamkulov, Sholpan Iglikova, Anar Rakisheva, Joseph Almazan

Abstract readReview

In one paragraph

Review in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

[Drug resistance characteristics of pulmonary tuberculosis and factors associated with rifampicin resistance in Changsha from 2018 to 2025].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
Article
Genomic Surveillance of 3R Genes Associated with Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ulan KozhamkulovCenter for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.

Sholpan IglikovaNational Scientific Center of Phthisiopulmonology of the Republic of Kazakhstan, Almaty 050000, Kazakhstan.

Anar RakishevaDepartment of Phthisiopulmonology, School of General Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.

Joseph AlmazanDepartment of Medicine, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.

Funding

Nazarbayev University 11022021CRP1511, Ulan Kozhamkulovthe Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP23490200

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Beijing genotypeCentral Asiamultidrug-resistant TBtuberculosiswhole genome sequencing

Identifiers

PMID40723976

DOI10.3390/antibiotics14070673

PMCPMC12291989

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.